✨ Regulatory and Educational Notices




16 FEBRUARY 2012 NEW ZEALAND GAZETTE, No. 17 419

864.95 865.95 866.95 867.95
865.05 866.05 867.05 868.05

Dated at Wellington this 13th day of February 2012.

SANJAI RAJ, Group Manager, Radio Spectrum Management, Ministry of Economic Development.

Explanatory Note

(This note is not part of the notice, but is intended to indicate its general effect).

This notice prescribes that, pursuant to Regulation-making powers of the Radiocommunications Act 1989, a general user radio licence is granted for the transmission of radio waves for the purpose of cordless telephony and telecommunications, including those known as "CT1", "CT2", "DECT", and "PHS", in accordance with the terms, conditions and restrictions of this notice.

This notice comes into force on 16 February 2012.

Cordless telephones may also operate in other bands pursuant to a General User Radio Licence for Short Range Devices.

New Zealand Gazette, 29 May 2003, No. 57, page 1597
go910

Education

Education Act 1989

Timaru Girls’ High School (361) Board of Trustees By-Election Invalidation Notice

Pursuant to Clause 9(3A) of the Sixth Schedule of the Education Act 1989, and acting with authority delegated by the Minister of Education, I declare invalid the 22 December 2011 by-election for the Timaru Girls’ High School Board of Trustees and require a new by-election to be held on 30 March 2012.

This notice takes effect the day after its publication in the New Zealand Gazette.

Dated at Wellington this 13th day of February 2012.

CAROLYN MURPHY, Acting Group Manager, Education, Curriculum and Performance.
go864

Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Maxiclear Sinus Relief
Active Ingredient: Phenylephrine hydrochloride 10mg equivalent to Phenylephrine 8.2mg
Dosage Form: Tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Sigma Laboratories Ltd, Goa, India

Dated this 9th day of February 2012.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go810

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Zelboraf
Active Ingredient: Vemurafenib 800mg equivalent to Vemurafenib base 240mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturer: Roche SpA, Milan, Italy

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 9th day of February 2012.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go811



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2012, No 17





✨ LLM interpretation of page content

πŸš‚ Radiocommunications Regulations for Cordless Telephones

πŸš‚ Transport & Communications
13 February 2012
Radiocommunications, Regulations, Cordless Telephones, Licence, Frequency Bands
  • SANJAI RAJ, Group Manager, Radio Spectrum Management, Ministry of Economic Development

πŸŽ“ Invalidation of Timaru Girls’ High School Board of Trustees By-Election

πŸŽ“ Education, Culture & Science
13 February 2012
Education, Board of Trustees, By-Election, Invalidation, Timaru Girls’ High School
  • CAROLYN MURPHY, Acting Group Manager, Education, Curriculum and Performance

πŸ₯ Consent to Distribution of Maxiclear Sinus Relief

πŸ₯ Health & Social Welfare
9 February 2012
Medicines, Consent, Distribution, Maxiclear Sinus Relief, Phenylephrine
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

πŸ₯ Provisional Consent to Distribution of Zelboraf

πŸ₯ Health & Social Welfare
9 February 2012
Medicines, Provisional Consent, Distribution, Zelboraf, Vemurafenib
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health